Is Boston Scientific a good stock to buy?

Is Boston Scientific a good stock to buy?

Valuation metrics show that Boston Scientific Corporation may be fairly valued. Its Value Score of C indicates it would be a neutral pick for value investors. The financial health and growth prospects of BSX, demonstrate its potential to perform inline with the market. It currently has a Growth Score of C.

Is Boston Scientific a buy or sell?

Boston Scientific has received a consensus rating of Buy.

What is the price of BSX?

44.22. 10.72 M. 01/14/22. 44.17. 44.95.

Is Boston Scientific publicly traded?

Boston Scientific Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol “BSX”. When did Boston Scientific become a publicly traded company? Boston Scientific’s IPO became effective in May 1992.

Is Boston Scientific a Fortune 500 company?

MARLBOROUGH, MA — Marlborough based company Boston Scientific made it onto the Fortune 500 list. Fortune Magazine released its annual list of the 500 top companies in America, which represent two-thirds of the U.S. GDP and have a total of $13.7 trillion in revenue, the magazine says.

When did Mahoney join Boston Science?

2011
Mahoney is chairman, president and chief executive officer at Boston Scientific Corporation and a member of the company’s board of directors. He first joined Boston Scientific in 2011, with a 24-year track record of building market-leading medical device, capital equipment and healthcare IT businesses.

Is Boston Dynamics a private company?

Summary. Founded in 1992 after a spin-off from the prestigious Massachusetts Institute of Technology, Boston Dynamics remains private to date. In 2020, Boston Dynamics had launched sales of its first commercial robot Spot.

Does Stryker own Boston Scientific?

28 /PRNewswire-FirstCall/ — Boston Scientific Corporation (NYSE: BSX) today announced the execution of a definitive agreement under which Stryker Corporation will acquire Boston Scientific’s Neurovascular business.

Who bought Boston Scientific?

This amount consists of $4.1 billion in purchase price for the Guidant assets, a loan of $900 million, and Abbott”s agreement to acquire $1.4 billion of Boston Scientific common stock.

How much do Boston Scientific sales reps make?

Average Boston Scientific Field Representative yearly pay in the United States is approximately $87,078, which is 74% above the national average.

What is the long-term outlook for Boston Scientific stock?

Boston Scientific Corp. quote is equal to 45.100 USD at 2021-09-08. Based on our forecasts, a long-term increase is expected, the “BSX” stock price prognosis for 2026-08-31 is 53.615 USD. With a 5-year investment, the revenue is expected to be around +18.88%.

Is Boston Scientific (BSX) a good investment?

If you are looking for stocks with good return, Boston Scientific Corp. can be a profitable investment option. Boston Scientific Corp. quote is equal to 45.100 USD at 2021-09-08. Based on our forecasts, a long-term increase is expected, the “BSX” stock price prognosis for 2026-08-31 is 53.615 USD.

What are analysts’ target prices for Boston Scientific’s stock?

22 equities research analysts have issued 12 month target prices for Boston Scientific’s stock. Their forecasts range from $36.20 to $50.00. On average, they expect Boston Scientific’s stock price to reach $45.2952 in the next twelve months.

What is the ticker symbol for Boston Scientific?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol “BSX.”. Boston Scientific Co. (NYSE:BSX) issued its earnings results on Wednesday, July, 24th. Boston Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019.

https://www.youtube.com/watch?v=JvSQTH3NQzw